Fig. 1: Deleterious variant type and frequency in EOC patients.
From: Multigene germline and somatic testing for epithelial ovarian cancer in China
A Distribution of pathogenicity of germline mutation carriers. B Distribution of genes with germline deleterious mutations. C Distribution of mutation types of BRCA1 and BRCA2. D Distribution of pathogenicity of somatic mutation carriers. E Distribution of genes with deleterious somatic mutations. F Distribution of mutation types of TP53 and BRCA1. G proportion of germline, somatic, and germline + somatic mutation carriers in genes, HRo refers to HR-related genes other than BRCA1 and BRCA2.
